These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35660515)

  • 1. Miniproteins in medicinal chemistry.
    Ciesiołkiewicz A; Lizandra Perez J; Berlicki Ł
    Bioorg Med Chem Lett; 2022 Sep; 71():128806. PubMed ID: 35660515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
    Avrutina O
    Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miniprotein Design: Past, Present, and Prospects.
    Baker EG; Bartlett GJ; Porter Goff KL; Woolfson DN
    Acc Chem Res; 2017 Sep; 50(9):2085-2092. PubMed ID: 28832117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystine-knot peptides: emerging tools for cancer imaging and therapy.
    Ackerman SE; Currier NV; Bergen JM; Cochran JR
    Expert Rev Proteomics; 2014 Oct; 11(5):561-72. PubMed ID: 25163524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering knottins as novel binding agents.
    Moore SJ; Cochran JR
    Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of miniproteins by the transfer of active sites onto small-size scaffolds.
    Stricher F; Martin L; Vita C
    Methods Mol Biol; 2006; 340():113-49. PubMed ID: 16957335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds.
    Vita C; Vizzavona J; Drakopoulou E; Zinn-Justin S; Gilquin B; Ménez A
    Biopolymers; 1998; 47(1):93-100. PubMed ID: 9692330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications.
    Kolmar H
    Curr Pharm Des; 2011 Dec; 17(38):4329-36. PubMed ID: 22204431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miniproteins as a Powerful Modality in Drug Development.
    Crook ZR; Nairn NW; Olson JM
    Trends Biochem Sci; 2020 Apr; 45(4):332-346. PubMed ID: 32014389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Developability and Evolvability of Synthetic Miniproteins as Ligand Scaffolds.
    McConnell A; Batten SL; Hackel BJ
    J Mol Biol; 2023 Dec; 435(24):168339. PubMed ID: 37923119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miniproteins as phage display-scaffolds for clinical applications.
    Zoller F; Haberkorn U; Mier W
    Molecules; 2011 Mar; 16(3):2467-85. PubMed ID: 21407148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles.
    Kintzing JR; Cochran JR
    Curr Opin Chem Biol; 2016 Oct; 34():143-150. PubMed ID: 27642714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC-Mediated Cellular Uptake of Miniproteins: Forsaking "Arginine Magic".
    Meng X; Li T; Zhao Y; Wu C
    ACS Chem Biol; 2018 Nov; 13(11):3078-3086. PubMed ID: 30272440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Engineering of Miniproteins.
    Ożga K; Berlicki Ł
    ACS Bio Med Chem Au; 2022 Aug; 2(4):316-327. PubMed ID: 37102166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
    Kolmar H
    FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.
    Van Herrewege Y; Morellato L; Descours A; Aerts L; Michiels J; Heyndrickx L; Martin L; Vanham G
    J Antimicrob Chemother; 2008 Apr; 61(4):818-26. PubMed ID: 18270220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations.
    Parthasarathy A; Anandamma SK; Kalesh KA
    Curr Med Chem; 2019; 26(13):2330-2355. PubMed ID: 29022499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors.
    Jurado S; Moog C; Cano-Muñoz M; Schmidt S; Laumond G; Ruocco V; Standoli S; Polo-Megías D; Conejero-Lara F; Morel B
    J Mol Biol; 2020 Sep; 432(20):5577-5592. PubMed ID: 32822695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing antibodies: engineering new binding proteins.
    Banta S; Dooley K; Shur O
    Annu Rev Biomed Eng; 2013; 15():93-113. PubMed ID: 23642248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.